DOUBLE-BLIND COMPARISON OF THE EFFECTS OF LONG-TERM TREATMENT WITH DOXAZOSIN OR ATENOLOL ON SERUM-LIPOPROTEINS

被引：51

作者：

LEHTONEN, A ^{[1
]}

HIMANEN, P ^{[1
]}

SARASTE, M ^{[1
]}

NIITTYMAKI, K ^{[1
]}

MARNIEMI, J ^{[1
]}

机构：

[1] SOCIAL INSURANCE INST, REHABIL RES CTR, SF-20700 TURK, FINLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 21卷

关键词：

D O I：

10.1111/j.1365-2125.1986.tb02857.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S77 / S81

页数：5

共 20 条

[1] AMES RP, 1976, LANCET, V1, P721
[2] BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
[3] METABOLIC CONSEQUENCES OF ATENOLOL AND PROPRANOLOL IN TREATMENT OF ESSENTIAL HYPERTENSION
DAY, JL
SIMPSON, N
METCALFE, J
PAGE, RL
[J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6156) : 77 - 80
[4] DISCRIMINATIVE VALUE OF LIPIDS AND APOPROTEINS IN CORONARY HEART-DISEASE
DEBACKER, G
ROSSENEU, M
DESLYPERE, JP
[J]. ATHEROSCLEROSIS, 1982, 42 (2-3) : 197 - 203
[5] THE EFFECT OF METOPROLOL AND ATENOLOL ON PLASMA HIGH-DENSITY LIPOPROTEIN LEVELS IN MAN
ENGLAND, JDF
SIMONS, LA
GIBSON, JC
CARLTON, M
[J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1980, 7 (03) : 329 - 333
[6] A LONG-TERM DOUBLE-BLIND COMPARISON OF DOXAZOSIN AND ATENOLOL IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION
FRICK, MH
HALTTUNEN, P
HIMANEN, P
HUTTUNEN, M
PORSTI, P
PITKAJARVI, T
POYHONEN, L
PYYKONEN, ML
REINIKAINEN, P
SALMELA, P
SARASTE, M
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 : S55 - S62
[7] GIDEZ LI, 1982, J LIPID RES, V23, P1206
[8] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY
GORDON, T
CASTELLI, WP
HJORTLAND, MC
KANNEL, WB
DAWBER, TR
[J]. AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) : 707 - 714
[9] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND ANTIHYPERTENSIVE DRUGS - OSLO STUDY
HELGELAND, A
HJERMANN, I
LEREN, P
ENGER, S
HOLME, I
[J]. BRITISH MEDICAL JOURNAL, 1978, 2 (6134) : 403 - 403
[10] EFFECT OF PINDOLOL ON SERUM-LIPIDS AND LIPID METABOLIZING ENZYMES
LEHTONEN, A
HIETANEN, E
MARNIEMI, J
PELTONEN, P
NISKANEN, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 : S445 - S448

← 1 2 →